Clinical Trial Update: THERAPY-HYBRID-BPA Trial [Phase 2]

View source ↗

Summary

Clinical trial update for THERAPY-HYBRID-BPA, a Phase 2 study sponsored by Okayama Medical Center.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypertension
• Pulmonary Hypertension

Snippet

Sponsor: National Hospital Organization Okayama Medical Center | Conditions: Hypertension, Pulmonary | Phase 2 | Status: UNKNOWN